NO973656L - Farmasöytisk blanding for parenteral anvendelse inneholdende en indolkarboksylsyre - Google Patents

Farmasöytisk blanding for parenteral anvendelse inneholdende en indolkarboksylsyre

Info

Publication number
NO973656L
NO973656L NO973656A NO973656A NO973656L NO 973656 L NO973656 L NO 973656L NO 973656 A NO973656 A NO 973656A NO 973656 A NO973656 A NO 973656A NO 973656 L NO973656 L NO 973656L
Authority
NO
Norway
Prior art keywords
carboxylic acid
pharmaceutical composition
parenteral use
use containing
indole carboxylic
Prior art date
Application number
NO973656A
Other languages
English (en)
Norwegian (no)
Other versions
NO973656D0 (no
Inventor
Andrea Lodi
Maria Teresa Rossato
Original Assignee
Glaxo Wellcome Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Spa filed Critical Glaxo Wellcome Spa
Publication of NO973656D0 publication Critical patent/NO973656D0/no
Publication of NO973656L publication Critical patent/NO973656L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO973656A 1995-02-11 1997-08-08 Farmasöytisk blanding for parenteral anvendelse inneholdende en indolkarboksylsyre NO973656L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9502695.1A GB9502695D0 (en) 1995-02-11 1995-02-11 Pharmaceutical composition
PCT/EP1996/000515 WO1996024376A1 (en) 1995-02-11 1996-02-08 Pharmaceutical composition for parenteral application containing an indole-carboxylic acid

Publications (2)

Publication Number Publication Date
NO973656D0 NO973656D0 (no) 1997-08-08
NO973656L true NO973656L (no) 1997-10-08

Family

ID=10769456

Family Applications (1)

Application Number Title Priority Date Filing Date
NO973656A NO973656L (no) 1995-02-11 1997-08-08 Farmasöytisk blanding for parenteral anvendelse inneholdende en indolkarboksylsyre

Country Status (18)

Country Link
US (2) US5886018A (hu)
EP (1) EP0809514A1 (hu)
JP (1) JPH10513464A (hu)
KR (1) KR19980702109A (hu)
AU (1) AU707220B2 (hu)
BR (1) BR9607433A (hu)
CA (1) CA2212041A1 (hu)
CZ (1) CZ252897A3 (hu)
EA (1) EA000211B1 (hu)
FI (1) FI973280A0 (hu)
GB (1) GB9502695D0 (hu)
HU (1) HUP9702448A2 (hu)
IL (1) IL117098A0 (hu)
NO (1) NO973656L (hu)
NZ (1) NZ300937A (hu)
PL (1) PL321734A1 (hu)
WO (1) WO1996024376A1 (hu)
ZA (1) ZA961051B (hu)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9502695D0 (en) * 1995-02-11 1995-03-29 Glaxo Spa Pharmaceutical composition
WO2003039540A2 (en) * 2001-11-09 2003-05-15 Sepracor Inc. D-amino acid oxidase inhibitors for learning and memory
US20040019075A1 (en) * 2002-05-29 2004-01-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg New formulation for the parenteral application of crobenetine
CZ2006427A3 (cs) 2003-12-29 2006-11-15 Sepracor Inc. Pyrrolové a pyrazolové inhibitory DAAO
US8809393B2 (en) 2005-02-01 2014-08-19 Troikaa Pharmaceuticals Ltd Injectable preparations of diclofenac and its pharmaceutically acceptable salts
US7884124B2 (en) * 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
US7579370B2 (en) * 2006-06-30 2009-08-25 Sepracor Inc. Fused heterocycles
US9737531B2 (en) 2012-07-12 2017-08-22 Glytech, Llc Composition and method for treatment of depression and psychosis in humans
AU2018284335A1 (en) 2017-06-12 2020-01-30 Glytech Llc. Treatment of depression with NMDA antagonists and D2/5HT2A or selective 5HT2A antagonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0347123A (ja) * 1989-05-05 1991-02-28 G D Searle & Co インドール―2―カルボキシレート化合物類を含有するcns疾患治療用組成物
WO1992001670A1 (en) * 1990-07-16 1992-02-06 Merrell Dow Pharmaceuticals Inc. Excitatory amino acid antagonists
GB9208492D0 (en) * 1992-04-16 1992-06-03 Glaxo Spa Heterocyclic compounds
GB9502695D0 (en) * 1995-02-11 1995-03-29 Glaxo Spa Pharmaceutical composition

Also Published As

Publication number Publication date
PL321734A1 (en) 1997-12-22
CA2212041A1 (en) 1996-08-15
KR19980702109A (ko) 1998-07-15
IL117098A0 (en) 1996-06-18
JPH10513464A (ja) 1998-12-22
WO1996024376A1 (en) 1996-08-15
AU4622896A (en) 1996-08-27
HUP9702448A2 (hu) 1999-10-28
NO973656D0 (no) 1997-08-08
US5886018A (en) 1999-03-23
EP0809514A1 (en) 1997-12-03
AU707220B2 (en) 1999-07-08
BR9607433A (pt) 1998-05-26
FI973280A (fi) 1997-08-08
EA199700095A1 (ru) 1998-02-26
US6020359A (en) 2000-02-01
MX9706044A (es) 1998-06-28
NZ300937A (en) 1999-02-25
CZ252897A3 (cs) 1998-03-18
EA000211B1 (ru) 1998-12-24
ZA961051B (en) 1996-09-11
GB9502695D0 (en) 1995-03-29
FI973280A0 (fi) 1997-08-08

Similar Documents

Publication Publication Date Title
RU94028888A (ru) Производные 1,3-замещенного циклоалкана и циклоалкена, смесь их изомеров или индивидуальные изомеры, их гидраты и соли, способ их получения и фармацевтическая композиция
YU23599A (sh) Stabilizovani antihistaminski sirup
KR900012911A (ko) 흥분성 아미노산 수용기 길항질 화합물
DK0889875T3 (da) Cycloproylalkansyrederivater
PT894084E (pt) Derivados de acido cinamico e sua utilizacao como antagonistas de integrina
RU95116357A (ru) Производные пирролидина и тиазолидина, способы их получения, способ разделения энантиомеров и фармацевтическая композиция на основе производных пирролидина и тиазолидина
AU625998B2 (en) Excitatory amino acid antagonists
NO973656L (no) Farmasöytisk blanding for parenteral anvendelse inneholdende en indolkarboksylsyre
TNSN92022A1 (fr) Procede de preparation de nouveaux derives de l'indole
NO20020771L (no) Peptidformulering med forlenget frigjöring
EA200000023A1 (ru) Производные 2-(-4-арил или гетероарил-пиперазин-1-илметил) -1h-индола
NO940523D0 (no) Nye pyrazin-derivater
KR940006580A (ko) 질병을 치료하기 위한 치환된 사이클로헥산 유도체
DE69524103D1 (de) Fluorinierte 2-nitroimidazole analoge zur detektion von hypoxischen tumorzellen
PT1233953E (pt) Novos derivados de benzotiadiazinas processo para a sua preparacao e as composicoes farmaceuticas que os contem
DK192982A (da) Fremgangsmaade til fremstilling af arylalkansyrederivater
KR880009018A (ko) 3-l-피로글루타밀-l-티아졸리딘-4-카르복실산 및 이의 제법
RU94038042A (ru) Производные гексагидроазепинов, фармацевтическая композиция на их основе и антипсихотропный агент
RU94046297A (ru) Новое бензодиазепиновое производное, способ его получения фармкомпозиция
EA199800189A1 (ru) Оптически активное производное фенилпиримидина в качестве анальгетика
EA199800701A1 (ru) БЕНЗО[С]ХИНОЛИЗИНОВЫЕ ПРОИЗВОДНЫЕ, ИХ ПОЛУЧЕНИЕ И ИСПОЛЬЗОВАНИЕ В КАЧЕСТВЕ ИНГИБИТОРОВ 5a-РЕДУКТАЗ
NO161620C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive 8-alkyltio-2-piperazino-pyrimido(5,4-d)pyrimidin-derivater.
ID26346A (id) PROSES PEMBUATAN TURUNAN ASAM 5-HIDROKSIBENZO (b)TIOFEN-3-KARBOKSILAT
GB1318050A (en) Indole derivatives
TR199700828T1 (xx) .Klavulanik asit tuzlar�.